Papers
50
Total Citations
1,069
H-Index
19
About
Peter Grimminger is a leading surgical oncologist whose research has profoundly shaped the field of minimally invasive and robotic esophageal surgery. His work centers on the treatment of esophageal cancer, with a particular focus on robot-assisted minimally invasive esophagectomy (RAMIE) — a technically demanding procedure that he has championed, refined, and helped standardize at an international level. Grimminger's most influential contributions include landmark comparative studies demonstrating RAMIE's clinical advantages over conventional minimally invasive approaches, most notably through propensity-matched analyses and the prospective randomized ROBOT-2 trial, which together have accumulated over 200 citations. His 2020 series reporting outcomes in 100 consecutive RAMIE patients established important benchmarks for European surgical practice, while his participation in worldwide multicenter studies through the Upper GI International Robotic Association underscored his global reach. Beyond clinical outcomes, Grimminger has made critical contributions to surgical education, publishing structured training pathway frameworks to ensure safe RAMIE implementation at high-volume centers. His technical papers on da Vinci Xi robotic approaches and anastomotic standardization have become essential references for surgeons adopting this complex procedure. With a cumulative citation count exceeding 580 across his top works, Grimminger stands as one of Europe's foremost authorities on robotic esophageal surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9Minimally invasive esophagectomy: clinical evidence and surgical techniques34 citations · 2020
- 10